Lifesci Capital Has Negative Outlook of AVBP FY2025 Earnings
ArriVent BioPharma, Inc. (NASDAQ:AVBP – Free Report) – Equities researchers at Lifesci Capital decreased their FY2025 earnings per share estimates for ArriVent BioPharma in a note issued to investors on Monday, March 3rd. Lifesci Capital analyst S. Slutsky now expects that the company will post earnings per share of ($3.97) for the year, down from […]
ArriVent BioPharma, Inc. (NASDAQ:AVBP – Free Report) – Equities researchers at Lifesci Capital decreased their FY2025 earnings per share estimates for ArriVent BioPharma in a note issued to investors on Monday, March 3rd. Lifesci Capital analyst S. Slutsky now expects that the company will post earnings per share of ($3.97) for the year, down from […]
